A Phase I Trial of the Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 21 Feb 2017
At a glance
- Drugs Sonidegib (Primary) ; Cisplatin; Etoposide
- Indications Small cell lung cancer
- Focus Adverse reactions
- 15 Feb 2017 Planned End Date changed from 1 Apr 2017 to 1 Apr 2018.
- 15 Feb 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.
- 16 Feb 2016 Planned End Date changed from 1 Apr 2016 to 1 Apr 2017 as reported by ClinicalTrials.gov.